|
|
||||||||

*
Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden; and
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan
Activation-induced cell death (AICD) of mature T cells plays an important role in the control of immune homeostasis and peripheral tolerance. TNFRs and Fas have been implicated in the induction of AICD. However, these molecules were shown to be dispensable, at least in some experimental systems, for downsizing of Ag-induced T cell expansions and development of tolerance in vivo. The conditions of T cell activation leading to T cell deletion in a death receptor-independent manner are not well characterized. Here we show that human CTLs die through a death receptor-independent apoptotic program upon triggering with a partially agonistic peptide ligand. This apoptotic process exhibits some features of T cell death due to lymphokine deprivation and is blocked by exogenous IL-2. Our data demonstrate that engagement of TCR by MHC-peptide complexes can trigger diverse apoptotic programs of AICD and that the choice between these programs is determined by the agonistic potency of MHC-peptide ligand.
This article has been cited by other articles:
![]() |
P. Sen, W. A. Charini, R. A. Subbramanian, E. R. Manuel, M. J. Kuroda, P. A. Autissier, and N. L. Letvin Clonal Focusing of Epitope-Specific CD8+ T Lymphocytes in Rhesus Monkeys following Vaccination and Simian-Human Immunodeficiency Virus Challenge J. Virol., January 15, 2008; 82(2): 805 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fischer, S. Voelkl, J. Berger, R. Andreesen, T. Pomorski, and A. Mackensen Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells Blood, December 15, 2006; 108(13): 4094 - 4101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kennedy and E. Celis T Helper Lymphocytes Rescue CTL from Activation-Induced Cell Death. J. Immunol., September 1, 2006; 177(5): 2862 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Uhlin, M. G. Masucci, and V. Levitsky Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes PNAS, June 28, 2005; 102(26): 9264 - 9269. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kan-Mitchell, B. Bisikirska, F. Wong-Staal, K. L. Schaubert, M. Bajcz, and M. Bereta The HIV-1 HLA-A2-SLYNTVATL Is a Help-Independent CTL Epitope J. Immunol., May 1, 2004; 172(9): 5249 - 5261. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sandalova, C.-H. Wei, M. G. Masucci, and V. Levitsky Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering PNAS, March 2, 2004; 101(9): 3011 - 3016. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nilges, H. Hohn, H. Pilch, C. Neukirch, K. Freitag, P. J. Talbot, and M. J. Maeurer Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein J. Virol., May 1, 2003; 77(9): 5464 - 5474. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, D. Liu, L. Hutt-Fletcher, A. Morgan, M. G. Masucci, and V. Levitsky Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4 Blood, May 15, 2002; 99(10): 3725 - 3734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Fujii, K. Shimizu, T. Shimizu, and M. T. Lotze Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ Blood, October 1, 2001; 98(7): 2143 - 2151. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |